Igtrion 100 Softgel Capsule contains 100 mg of natural micronized progesterone, a bioidentical hormone essential for regulating various physiological functions related to the female reproductive system. Progesterone plays a critical role in the menstrual cycle, supporting implantation and maintenance of pregnancy, and modulating the endometrial lining. Igtrion 100 is indicated for hormone replacement therapy in conditions such as luteal phase deficiency, amenorrhea, and as part of assisted reproductive technologies. It is also utilized in the management of menopausal symptoms and prevention of endometrial hyperplasia in women undergoing estrogen therapy. The natural micronized form enhances absorption and bioavailability, ensuring effective plasma levels. Administration should be guided by a healthcare professional, with dosage tailored to individual therapeutic needs. Common adverse effects may include dizziness, headache, breast tenderness, and mild gastrointestinal discomfort. Contraindications include known hypersensitivity to progesterone, unexplained vaginal bleeding, active thromboembolic disorders, and certain hormone-dependent malignancies. Caution is advised in patients with hepatic impairment or a history of cardiovascular disease. Regular monitoring and follow-up are recommended to assess therapeutic response and detect any adverse reactions. Igtrion 100 Softgel Capsule should be stored at room temperature, protected from moisture and light.